Next Article in Journal / Special Issue
Non-Invasive Screening Tools for Down’s Syndrome: A Review
Previous Article in Journal
Quantification of Right and Left Ventricular Function in Cardiac MR Imaging: Comparison of Semiautomatic and Manual Segmentation Algorithms
Previous Article in Special Issue
Prenatal Diagnosis of Chromosome Abnormalities: A 13-Year Institution Experience
Open AccessArticle

Overview of Five-Years of Experience Performing Non-Invasive Fetal Sex Assessment in Maternal Blood

1
Genetics Department, Fundacion Jimenez Diaz, Avda, Reyes Catolicos 2, Madrid 28040, Spain
2
Centre for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Valencia 46010, Spain
3
Gynecology and Obstetric Department, Fundacion Jimenez Diaz, Avda, Reyes Catolicos 2, Madrid 28040, Spain
*
Author to whom correspondence should be addressed.
Diagnostics 2013, 3(2), 283-290; https://doi.org/10.3390/diagnostics3020283
Received: 15 March 2013 / Revised: 26 April 2013 / Accepted: 6 May 2013 / Published: 15 May 2013
(This article belongs to the Special Issue Advance in Prenatal Diagnosis)
Since the discovery of the presence of fetal DNA in maternal blood, non-invasive fetal sex determination has been the test most widely translated into clinical practice. To date there is no agreement between the different laboratories performing such tests in relation to which is the best protocol. As a consequence there are almost as many protocols as laboratories offering the service, using different methodologies and thus obtaining different diagnostic accuracies. By the end of 2007, after a validation study performed in 316 maternal samples collected between the 5th and 12th week of gestation, the fetal sex determination was incorporated into clinical practice in our Service. The test is performed in the first trimester of pregnancy, and it is offered as part of the genetic counseling process for couples at risk of X-linked disorders. As a general rule and in order to avoid misdiagnosis, two samples at different gestational ages are tested per patient. The analysis is performed by the study of the SRY gene by RT-PCR. Two hundred and twenty six pregnancies have been tested so far in these 5 years. Neither false positives nor false negatives diagnoses have been registered, thus giving a diagnostic accuracy of 100%. View Full-Text
Keywords: non-invasive prenatal diagnosis; fetal DNA; maternal plasma; fetal sex determination non-invasive prenatal diagnosis; fetal DNA; maternal plasma; fetal sex determination
Show Figures

Figure 1

MDPI and ACS Style

Perlado-Marina, S.; Bustamante-Aragones, A.; Horcajada, L.; Trujillo-Tiebas, M.J.; Lorda-Sanchez, I.; Ruiz Ramos, M.; Plaza, J.; Rodriguez de Alba, M. Overview of Five-Years of Experience Performing Non-Invasive Fetal Sex Assessment in Maternal Blood. Diagnostics 2013, 3, 283-290.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop